Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 19, 2018 CDNA A 9,638 · · 9,638 Direct · Acquired (price as of 2026-10-02)
Jan. 19, 2018 CDNA A 9,638 · · 9,638 Direct · Acquired (price as of 2026-10-02)
Feb. 17, 2017 CDNA A 27,000 · · 27,000 Direct · Acquired (price as of 2026-10-02)
Feb. 17, 2017 CDNA A 10,000 · · 20,000 Direct +100.00% Acquired (price as of 2026-10-02)
June 10, 2016 CDNA A 10,000 · · 10,000 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 19, 2018 CDNA Employee Stock Option (right to buy) Common Stock (9,638) $6.31 Jan. 19, 2028 9,638 Acquired
Feb. 17, 2017 CDNA Employee Stock Option (right to buy) Common Stock (27,000) $2.30 Feb. 17, 2027 27,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).